Trial Profile
A Phase 1, Repeat Dose Study to Evaluate the Safety, Tolerability, Biological Activity, and Pharmacokinetics of ND-L02-s0201 Injection in Japanese Subjects with Advanced Hepatic Fibrosis (METAVIR F3-4)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs BMS-986263 (Primary)
- Indications Hepatic fibrosis
- Focus Adverse reactions
- Sponsors Nitto Denko
- 14 Apr 2018 Results of this Japanese phase 1b study, presented at The International Liver Congress 2018.
- 25 Dec 2017 Status changed from active, no longer recruiting to completed.
- 16 Apr 2017 Status changed from recruiting to active, no longer recruiting.